Last year, a group of scientists posted an article called ‘Bioactive pyrrole-based compounds with target selectivity'.
According to an analysis by Vitaku et al. N-heterocycles are the most common structural skeletons of pharmaceuticals on the market.
Our todays’ review is focused on pyrrole and its hetero-fused derivatives with anticancer, antimicrobial, and antiviral activities.
The authors analyzed the most representative targets of recently developed compounds, for which selectivity towards a specific target was proven.
Based on the article, we prepared a great set of compounds, that include pyrrole moiety!
It is already available by this link!